Insider · CIK 0001532230

Milligan John C.K. IV

CIK 0001532230 Name as filed on the most recent filing

Filed as Milligan John C.K. IV (16)

28 transaction lines · from 16 filings · filed 2014-01-30 to 2021-05-12 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

28 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2021-05-11 S, Open-market sale TherapeuticsMD, Inc.TXMD 46,022, disposed Open Form 4 filing 0001387131-21-005567
2019-10-25 P, Open-market purchase TherapeuticsMD, Inc.TXMD 198,000, acquired Open Form 4 filing 0001387131-19-007990
2019-10-25 P, Open-market purchase TherapeuticsMD, Inc.TXMD 198,000, acquired Open Form 4 filing 0001387131-19-007992
2019-08-16 P, Open-market purchase TherapeuticsMD, Inc.TXMD 29,300, acquired Open Form 4 filing 0001387131-19-006246
2019-08-12 P, Open-market purchase TherapeuticsMD, Inc.TXMD 47,400, acquired Open Form 4 filing 0001387131-19-006150
2018-12-18 S, Open-market sale TherapeuticsMD, Inc.TXMD 469,635, disposed Open Form 4 filing 0001387131-18-006855
2018-12-17 S, Open-market sale TherapeuticsMD, Inc.TXMD 483,750, disposed Open Form 4 filing 0001387131-18-006855
2018-12-06 S, Open-market sale TherapeuticsMD, Inc.TXMD 589,530, disposed Open Form 4 filing 0001387131-18-006632
2018-12-04 S, Open-market sale TherapeuticsMD, Inc.TXMD 642,162, disposed Open Form 4 filing 0001387131-18-006632
2018-11-29 S, Open-market sale TherapeuticsMD, Inc.TXMD 650,030, disposed Open Form 4 filing 0001387131-18-006478
2018-11-28 S, Open-market sale TherapeuticsMD, Inc.TXMD 630,294, disposed Open Form 4 filing 0001387131-18-006478
2018-11-15 S, Open-market sale TherapeuticsMD, Inc.TXMD 643,581, disposed Open Form 4 filing 0001387131-18-006314
2018-11-14 S, Open-market sale TherapeuticsMD, Inc.TXMD 621,651, disposed Open Form 4 filing 0001387131-18-006314
2018-10-24 S, Open-market sale TherapeuticsMD, Inc.TXMD 671,250, disposed Open Form 4 filing 0001387131-18-005637
2018-10-23 S, Open-market sale TherapeuticsMD, Inc.TXMD 666,250, disposed Open Form 4 filing 0001387131-18-005637
2018-10-10 S, Open-market sale TherapeuticsMD, Inc.TXMD 719,625, disposed Open Form 4 filing 0001387131-18-005414
2018-10-09 S, Open-market sale TherapeuticsMD, Inc.TXMD 743,125, disposed Open Form 4 filing 0001387131-18-005414
2018-09-26 S, Open-market sale TherapeuticsMD, Inc.TXMD 847,000, disposed Open Form 4 filing 0001387131-18-005028
2018-09-25 S, Open-market sale TherapeuticsMD, Inc.TXMD 847,250, disposed Open Form 4 filing 0001387131-18-005028
2018-09-11 S, Open-market sale TherapeuticsMD, Inc.TXMD 765,750, disposed Open Form 4 filing 0001387131-18-004676
2018-09-10 S, Open-market sale TherapeuticsMD, Inc.TXMD 758,125, disposed Open Form 4 filing 0001387131-18-004676
2014-03-26 S, Open-market sale TherapeuticsMD, Inc.TXMD 2,366,836, disposed Open Form 4 filing 0001387131-14-001136
2014-02-26 S, Open-market sale TherapeuticsMD, Inc.TXMD 54,839, disposed Open Form 4 filing 0001387131-14-000686
2014-02-25 S, Open-market sale TherapeuticsMD, Inc.TXMD 51,117, disposed Open Form 4 filing 0001387131-14-000686
2014-02-24 S, Open-market sale TherapeuticsMD, Inc.TXMD 51,735, disposed Open Form 4 filing 0001387131-14-000686
2014-01-30 S, Open-market sale TherapeuticsMD, Inc.TXMD 54,553, disposed Open Form 4 filing 0001387131-14-000345
2014-01-29 S, Open-market sale TherapeuticsMD, Inc.TXMD 50,050, disposed Open Form 4 filing 0001387131-14-000345
2014-01-28 S, Open-market sale TherapeuticsMD, Inc.TXMD 49,315, disposed Open Form 4 filing 0001387131-14-000345

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
O, Officer
Officer
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 4
  • Open-market sale 24
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Milligan John C.K. IV, insider transactions. Retrieved 2026-08-24 from https://ebomi.com/insider/0001532230

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.